Neural substrates underlying the effects of oxytocin: a quantitative meta-analysis of pharmaco-imaging studies

Soc Cogn Affect Neurosci. 2017 Oct 1;12(10):1565-1573. doi: 10.1093/scan/nsx085.

Abstract

The hypothalamic peptide oxytocin (OT) is crucial in social adaptation and used to treat emotional and social deficits. Here, we conducted a systematic, quantitative meta-analysis of functional-MRI studies intranasally administering OT (IN-OT) to uncover neural substrates underlying the IN-OT effects and to elucidate differential IN-OT effects between healthy and clinical populations. Meta-analyses were conducted on 66 IN-OT fMRI studies, stratified by psychopathology, valence and sex. IN-OT increased bilateral amygdala, caudate head, and superior temporal activity in healthy individuals and increased dorsal anterior cingulate activity in patients. Moreover, IN-OT decreased amygdala activity in both patients and healthy individuals but did so to a greater degree in patients than healthy individuals. The OT-increased amygdala activity was only found on the negative social and affective processes, whereas the OT-decreased amygdala activity was mainly contributed by contrasts on negative-valenced processes. IN-OT increased parahippocampal activity and decreased amygdala activity during negative socio-affective processing. During positive socio-affective processes, IN-OT increased caudate head activity. This study indicates convergent neural substrates and the underlying neuropsychological mechanisms for IN-OT effects on social and affective processes. The common and different effects of IN-OT on patients and healthy individuals and the modulation of OT effects by valence have critical implications.

Keywords: amygdala; fMRI; meta-analysis; oxytocin; social adaptation.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Affect / drug effects
  • Brain / diagnostic imaging
  • Brain / drug effects
  • Emotions / drug effects
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mental Disorders / drug therapy
  • Oxytocin / pharmacology*
  • Oxytocin / therapeutic use

Substances

  • Oxytocin